AMID its ongoing efforts to police counterfeit and unregistered health products, the Food and Drug Administration (FDA) is set to come out with guidelines on how to handle those that have been seized from the market.
In a statement, the FDA said there is a need to establish guidelines for the handling of violative health products that were taken out of the market.
“A technical working group (TWG) is tasked to develop and implement guidelines in relation to proper handling, storage, and disposal of seized health products,” said the FDA.
Dubbed as “Oplan Katharos,” the FDA said the TWG is mandated to set correct protocols for managing the transportation, receipt, handling, storage, and disposal of collected or seized health products.
“It is designed to align with national and international environmental conservation and recovery standards, thus demonstrating our commitment to these principles,” said the FDA.
To note, the FDA has been regularly monitoring counterfeit, adulterated, misbranded, and unregistered processed food, devices, drugs, cosmetics, household hazardous substances, and other health products.
Its efforts include calling on local government units and law enforcement agencies to ensure that such products are not made available in their areas of jurisdiction. — Gerard Naval
